We are thrilled to announce that VRG Therapeutics has been selected to present in front of top-tier VC investors in the Startup Spotlight competition at Bio Europe 2023, organized with the support of Bayer Co.Lab incubator. We pitch our Kv1.3 asset aiming to cure autoimmune diseases. You'll have the opportunity to meet with Zalán Péterfi MD, PhD and Márton Megyeri, PhD at the event in München. Register now to join us!
Introduction
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
October 11, 2023
SHARE THIS ON
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
October 11, 2023
SHARE THIS ON
Introduction
Latest
News
The latest industry news, interviews, technologies, and resources.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
